Correlation Between BB Biotech and Swiss Life
Can any of the company-specific risk be diversified away by investing in both BB Biotech and Swiss Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BB Biotech and Swiss Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BB Biotech AG and Swiss Life Holding, you can compare the effects of market volatilities on BB Biotech and Swiss Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BB Biotech with a short position of Swiss Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of BB Biotech and Swiss Life.
Diversification Opportunities for BB Biotech and Swiss Life
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between BION and Swiss is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding BB Biotech AG and Swiss Life Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Swiss Life Holding and BB Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BB Biotech AG are associated (or correlated) with Swiss Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Swiss Life Holding has no effect on the direction of BB Biotech i.e., BB Biotech and Swiss Life go up and down completely randomly.
Pair Corralation between BB Biotech and Swiss Life
Assuming the 90 days trading horizon BB Biotech AG is expected to generate 2.14 times more return on investment than Swiss Life. However, BB Biotech is 2.14 times more volatile than Swiss Life Holding. It trades about 0.21 of its potential returns per unit of risk. Swiss Life Holding is currently generating about 0.21 per unit of risk. If you would invest 2,725 in BB Biotech AG on April 22, 2025 and sell it today you would earn a total of 580.00 from holding BB Biotech AG or generate 21.28% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
BB Biotech AG vs. Swiss Life Holding
Performance |
Timeline |
BB Biotech AG |
Swiss Life Holding |
BB Biotech and Swiss Life Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BB Biotech and Swiss Life
The main advantage of trading using opposite BB Biotech and Swiss Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BB Biotech position performs unexpectedly, Swiss Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Swiss Life will offset losses from the drop in Swiss Life's long position.BB Biotech vs. Swiss Life Holding | BB Biotech vs. Swiss Re AG | BB Biotech vs. Helvetia Holding AG | BB Biotech vs. Partners Group Holding |
Swiss Life vs. Zurich Insurance Group | Swiss Life vs. Swiss Re AG | Swiss Life vs. Swisscom AG | Swiss Life vs. Lonza Group AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world |